| CGTX Average Annual Return Chart Since 2021 | |||
Also see: • CGTX stock yearly return 2022 • CGTX stock yearly return 2023 • CGTX stock yearly return 2024 • CGTX stock yearly return 2025 • CGTX YTD return | |||
| Average Annual Return Benchmarks |
|
Compare CGTX average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CGTX Share Performance |
| CGTX Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
CGTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Cognition Therapeutics Inc |
| Cognition Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for age-related degenerative disorders of the central nervous system and retina. Its lead candidate, CT1812, is being investigated for Alzheimer's disease, dementia with Lewy bodies, and dry age-related macular degeneration (dry AMD). CT1812 is an orally delivered modulator that crosses the blood-brain and blood-retina barriers, selectively binding to the sigma-2 receptor (S2R) complex. This modulation restores normal synapse function and critical cellular processes like autophagy, cholesterol biosynthesis, and vesicle trafficking. The CGTX average annual return since 2021 is shown above.
The Average Annual Return on the CGTX average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether CGTX average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CGTX average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CGTX Current Stock Quote |
 Free CGTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Cognition Therapeutics (CGTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
CHE Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!